Code
F2018/IOF-ConcepTT/455
Looptijd
01-01-2019 → 31-03-2021
Financiering
Regional and community funding: Industrial Research Fund
Promotor
Onderzoeksdisciplines
-
Medical and health sciences
- Vaccinology
Trefwoorden
Immunoglobuline genen
Genetische modificatie
B cel receptor
gepersonaliseerde geneeskunde
B lymfocyt
CRISPR/Cas9, T cel receptor, T lymfocyt, Antilichamen, Synthetische immuniteit
Projectomschrijving
Transferred Immunity by Gene Editing of Antigen Receptors (TIGEAR) could become a challenging technology that would completely change the current view of immunity, immunization and vaccination. The primary purpose of this ConcepTT application is to generate proof-of-concept data.